Our longitudinal cohort study was aimed at addressing these gaps by systematically evaluating 5-year trajectories of both eGFR and urinary albumin excretion rate (AER) in adults with Type 2 diabetes mellitus (T2DM). This evidence concerns the gene ALB and type 2 diabetes mellitus.